Inquiry Basket
Eicosanedioic acid is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker.
| Catalog Number | Size | Price | Quantity | ||
|---|---|---|---|---|---|
| BADC-01923 | -- | $-- | Inquiry |
Eicosanedioic acid, a long-chain dicarboxylic acid with the molecular formula C20H38O4, plays a critical role in pharmaceutical chemistry. Its structure, consisting of a 20-carbon alkyl chain flanked by carboxylic acid groups at both ends, confers unique properties that are highly valued in the development of therapeutic agents. The substantial hydrophobic core of the eicosanedioic acid molecule provides significant advantages when employed as a linker in drug conjugation technologies. In the realm of antibody-drug conjugates (ADCs), this compound serves as a non-cleavable linker, facilitating the stable and targeted delivery of cytotoxic drugs to cancer cells, thereby minimizing off-target effects and enhancing therapeutic efficacy.
The application of eicosanedioic acid extends beyond ADCs. In the realm of small molecule drug discovery, it is harnessed as a key component in the design of PROteolysis TArgeting Chimeras (PROTACs). These are bifunctional molecules engineered to target specific proteins for degradation via the ubiquitin-proteasome pathway. Eicosanedioic acid serves as a crucial linker that connects the target-binding ligand with the E3 ubiquitin ligase ligand. The rigidity and optimal length of the eicosanedioic acid linker ensure the correct spatial orientation necessary for the effective recruitment of the targeted protein to the proteasome, thereby facilitating its degradation. This innovative approach has unlocked new therapeutic possibilities for previously “undruggable” targets, marking a significant advancement in cancer therapy and other areas.
The dual utility of eicosanedioic acid in both ADCs and PROTACs underlines its versatility and significance in the field of medicinal chemistry. As a stable linker, it contributes to the pharmacokinetic properties and bioavailability of the conjugated drugs. In ADCs, the use of a non-cleavable linker like eicosanedioic acid ensures that the cytotoxic payload remains attached to the antibody until it is internalized by the target cell, thereby maximizing its potency. In contrast, the use of eicosanedioic acid in PROTACs underscores the molecule’s adaptability and effectiveness in mediating protein-protein interactions necessary for targeted protein degradation.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
